In this roundtable, our panel of scientists will highlight the adoption of biomarker strategies that can create efficiency in your clinical cell therapy development efforts. Specific areas of focus ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a ...

Dementia can be predicted in women up to 25 years before symptoms begin through a simple blood test, according to new research. A protein measured in blood samples is "strongly linked" to the future ...

The company reiterated that the ASPEN-Breast Phase II trial is "on track to dose its first patient this quarter," with interim data expected in Q3 2026. ALX2004 initial safety data is expected in the ...

With IVDR performance study guidance now in force, German reimbursement reforms underway, and NHS England advancing liquid biopsy rollouts, Europe is entering a new era of precision medicine. As novel ...

Different genomic alterations in DNA damage repair (DDR) pathways occur in 20% to 25% of advanced prostate cancer, including homologous recombination repair (HRR) gene alterations. Identifying the ...

We included 77 studies: 47 studies reported factors from clinicians' perspective, 33 studies reported patients' perspective, 23 studies reported implementation strategies, and seven studies evaluated ...